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Background: Neonatal mortality remains high in sub-Saharan Africa, and 
a third of deaths are estimated to result from infection. While coagulase-
negative staphylococci (CoNS) are leading neonatal pathogens in resource-
rich settings, their role, and the need for early anti-Staphylococcal treatment 
in empiric antibiotic guidelines, is unknown in sub-Saharan Africa.
Methods: We examined systematic clinical and microbiologic surveillance 
data from all neonatal admissions to Kilifi County Hospital (1998–2013) 
to determine associated case fatality and/or prolonged duration of admis-
sion associated with CoNS in neonates treated according to standard World 
Health Organization guidelines.
Results: CoNS was isolated from blood culture in 995 of 9552 (10%) neo-
nates. Case fatality among neonates with CoNS isolated from blood did not 
differ from other neonatal admissions (P = 0.2), and duration of admission 
was not prolonged [odds ratio (OR) = 0.9 (0.7–1.0), P = 0.040]. Neonates 
with CoNS were more likely to have convulsions [OR = 1.4 (1.0–1.8), P = 
0.031] but less likely to have impaired consciousness or severe indrawing 
[OR = 0.8 (0.7–0.9), P = 0.025; OR = 0.9 (0.7–1.0), P = 0.065].
Conclusions: CoNS isolation in blood cultures at admission was not associ-
ated with adverse clinical outcomes in neonates treated according to standard 
World Health Organization guidelines for hospital care in this setting. There 
is no evidence that first-line antimicrobial treatment guidelines should be 
altered to increase cover for CoNS infections in neonates in this setting.
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While advances have been made in reducing global deaths in children under 5 years old, neonatal mortality remains high, 
with the greatest burden in sub-Saharan Africa. Around a third of 
neonatal deaths are attributed to infection, and there is also a con-
siderable burden of morbidity because of subsequent disability.1,2
Data on the etiology of neonatal infection remain limited,3 
and improving our understanding of this is essential to guide treat-
ment strategies. Most cases of possible serious bacterial infection 
(pSBI) in neonates in sub-Saharan Africa are treated empirically 
according to World Health Organization (WHO) guidelines in the 
absence of access to microbiologic laboratory facilities. The first-
line antimicrobials recommended are amoxicillin and gentamicin, 
unless Staphylococcal infection is suspected from clinical signs 
such as skin pustules or abscesses.4,5
In resource-rich settings, coagulase-negative Staphylococci 
(CoNS) have emerged as leading pathogens in certain vulnerable 
patient groups, including neonates, particularly if they are preterm.6,7 
This is associated with greater use of indwelling medical devices, 
such as peripherally inserted central catheters, and ventilators, which 
CoNS have the ability to colonize through the formation of bio-
films.6,8,9 CoNS infection also increases morbidity because of chronic 
lung disease and adverse neurodevelopmental outcomes, as well as 
being associated with prolonged hospital stay.10 However, CoNS is 
not strongly associated with increased mortality,11 compared, for 
example, with Staphylococcus aureus or Gram-negative infections.12
In resource-poor settings, such as sub-Saharan Africa, CoNS 
are variably reported as clinically significant,13–18 or not,19–23 and in 
neonates account for 6%–32%13,15,24 of all positive blood cultures. 
Assessing their clinical importance is difficult; they are common 
skin commensals and can thus contaminate samples. Levels of med-
ical support are usually lower than resource-rich settings,25 which 
may make isolation of CoNS less likely to be clinically significant, 
but particularly as the proportion of preterm births is high, this is 
an important question to answer.26 There are limited data currently 
available, with few pathogen-specific mortality outcomes reported.
Data from a tertiary care unit in South Africa reported low 
case fatality (2%),27 but data from lower level health facilities are 
lacking.
This study therefore aimed to examine whether CoNS iso-
lated in blood cultures from neonates admitted to a rural hospital in 
Kenya, treated according to standard WHO guidelines, were asso-
ciated with death, prolonged hospital duration or specific clinical 
features of pSBI. To do this, the specific objectives were to test the 
association between death, prolonged hospital duration or features 
of pSBI in the following:
1. Neonates with CoNS isolated from blood cultures compared 
with all other admissions (primary analysis).
2. Neonates with CoNS isolated from blood cultures compared 
with other admissions excluding those with clinically signifi-
cant organisms isolated.
3. Neonates with CoNS isolated from blood cultures compared 
with neonates with clinically significant isolates in blood cul-
tures.
4. Neonates with clinically significant isolates in blood cultures 
compared with all other admissions.
5. Neonates with clinically nonsignificant or uncertain signifi-
cance isolates (excluding CoNS) compared with all other 
admissions.
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. This 
is an open access article distributed under the Creative Commons Attribu-
tion License 4.0 (CCBY), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
ISSN: 0891-3668/17/3611-1073
DOI: 10.1097/INF.0000000000001699
Should First-line Empiric Treatment Strategies for Neonates 
Cover Coagulase-negative Staphylococcal Infections in Kenya?
Anna C. Seale, DPhil,*†‡ Christina W. Obiero, MBChB, MPH,*† Kelsey D. Jones, PhD,*§  
Hellen C. Barsosio, MBChB,* Johnstone Thitiri, MSc,* Moses Ngari, MSc,* Susan Morpeth, PhD,*‡  
Shebe Mohammed, HND,* Gregory Fegan, PhD,*† Neema Mturi, MRCP,* and James A. Berkley, FRCPCH*†
Accepted for publication March 10, 2017.
From the *Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research 
Institution, Kilifi, Kenya; †University of Oxford, Oxford, United Kingdom; 
and ‡London School of Hygiene and Tropical Medicine, and §Imperial Col-
lege London, London, United Kingdom.
This work was supported by The Wellcome Trust, United Kingdom. Grant num-
bers [093804 to ACS, 092088 to KJ, 083579 to JAB and 077092 core grant 
to the KEMRI Wellcome Trust Research Programme]. 
The authors have no conflicts of interest to disclose.
This study is published with the permission of the Director of Kenya Medical 
Research Institute. Surveillance at Kilifi County Hospital was undertaken at 
the Kenya Medical Research Institute/Wellcome Trust Research Programme. 
Address for correspondence: Anna C Seale, DPhil, KEMRI-Wellcome Trust 
Research Programme, PO Box 230, Kilifi, 80108, Kenya. E-mail: anna.
seale@lshtm.ac.uk.
Supplemental digital content is available for this article. Direct URL citations 
appear in the printed text and are provided in the HTML and PDF versions of 
this article on the journal’s website (www.pidj.com).
Copyright © 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Seale et al The Pediatric Infectious Disease Journal • Volume 36, Number 11, November 2017
1074 | www.pidj.com © 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
METHODS
Study Design and Setting
This retrospective cohort study was undertaken using sys-
tematic clinical and microbiologic surveillance data from Kilifi 
County Hospital (KCH). KCH serves Kilifi County, which had a 
population of 540,000 in 2009, and covers a large catchment area 
(12,246 km2). The main local economy is subsistence farming,28 
and nearly 3 quarters of the population live below the nationally 
defined poverty line.29 KCH provides pediatric care with ~4000 
admissions each year and comprehensive maternity care for ~3000 
deliveries each year. It serves as a referral center for peripheral 
health facilities.
Recruitment
All neonates (0–27 days) admitted to the hospital between 
August 1, 1998, and December 31, 2013 were included in this 
study, unless admitted for elective procedures. The sample size was 
determined by the number of admissions during the surveillance 
period.
Clinical Investigation
Systematic clinical admission data were collected on all 
neonatal admissions and prospectively entered into databases. This 
included the presence of signs of pSBI, as defined by the Young 
Infants Clinical Signs Study,30 including difficulty feeding, con-
vulsions, reduced conscious level, hypothermia or fever, high res-
piratory rate, movement only when stimulated and chest wall in-
drawing. Other measurements included anthropometry (admission 
weight) and routine clinical investigations (hematology, biochem-
istry and blood culture) for all neonatal admissions. Cerebrospinal 
fluid (CSF) was sampled where there was no contraindication; how-
ever, CoNS were not systematically reported in CSF. Since 2007, 
HIV testing has been offered routinely, in line with national guide-
lines for provider- initiated testing in Kenya.
At KCH, neonates are treated according to standard pro-
tocols, based on WHO guidelines.4,31 These include intravenous 
ampicillin and gentamicin as first-line antimicrobials,4 and usually 
a third generation cephalosporin as second line. KCH was reliably 
supplied with intravenous cannulas, first- and second-line empiric 
antibiotics and oxygen during the study period. Medical officers 
were trained in neonatal resuscitation, but neonatal ventilation was 
not available and peripherally inserted central catheters were not 
in use. No specific treatment was initiated as a result of isolating 
CoNS from blood and species identification, and antimicrobial sus-
ceptibility testing were not performed.
Sampling
Clinical procedures have been described previously.21 
Briefly, for blood cultures, an aseptic technique was used and 
blood was inoculated into a blood culture bottle (BACTEC Peds 
Plus; Becton Dickinson, Franklin Lakes, NJ). Blood culture bot-
tles were weighed before and after inoculation and processed with 
an automated blood culture system (BACTEC 9050; Becton Dick-
inson). Positive blood cultures were cultured on standard media. 
CoNS were reported, but species were not determined, and CoNS 
isolates were not stored or tested for antibiotic susceptibilities, 
as they were not regarded as clinically significant. All laboratory 
procedures were internally controlled, and the KEMRI-Wellcome 
Trust Research Laboratories were externally monitored for qual-
ity assurance by the United Kingdom National External Quality 
Assessment Service and were Good Clinical Laboratory Practice–
accredited by Qualogy, United Kingdom, since 2007. From 2009, 
a working group was formed as a quality improvement activity to 
reinforce training in aseptic technique with oversight and feedback 
of rates of presumed contaminants.
Analysis
Clinical data were extracted from databases and merged with 
laboratory databases using unique numerical identifiers to link data 
(personal identifiers were removed). Data analysis was performed 
with STATA version 13 (Stata Corp, College Station, TX). Data 
were described, and univariable and multivariable logistic regres-
sion analyses done for each objective, adjusting in each, for age, 
sex and volume of blood for culture a priori. The volume of blood 
for culture was included as a potential confounder a priori because 
if blood sampling was difficult, a small sample was considered 
more likely to have been obtained (eg, from a neonate with poor 
peripheral circulation), and contamination more likely. All clinical 
signs associated with CoNS isolation in univariable analyses (P < 
0.1) were included in the multivariable model for each analysis, 
with backwards stepwise regression based on the likelihood ratio 
test (LRT) used to determine the final model.
For the first objective, and primary analysis, the unexposed 
group were all neonates who had a blood culture without CoNS 
isolated from blood. This analysis was chosen because CoNS can 
mask the growth of other organisms, and if those with CoNS iso-
lated were compared with only those with no pathogen isolated, 
increased mortality caused by CoNS could be because of known 
pathogens being masked by CoNS. However, to investigate differ-
ences between children with CoNS and those with other specific 
blood stream infection categories, other comparisons were made 
as per objectives 2 and 3, as well as comparing neonates with clini-
cally significant isolates to all others as per objective 4 and neonates 
with other clinically nonsignificant isolates or isolates of unknown 
significance from blood culture (Bacillus spp., Coryneforms, Mic-
rococcus spp. and Viridans-group Streptococci) compared with all 
others, as per objective 5.
Ethical Review
This study was approved by KEMRI National Ethical 
Review Committee, Nairobi, (SSC/ERC 2906). This analysis was 
a retrospective review of systematically collected routine clinical 
data and laboratory findings for a neonatal admissions to KCH.
RESULTS
Participants
There were 10,058 neonates admitted to KCH between the 
August 1, 1998, and December 31, 2013. Of these, 15 (0.1%) were 
ineligible as they were admitted for elective surgery. A further 115 
(1.1%) were eligible but excluded from the analysis as outcome 
data were missing. There were 376 (3.7%) neonates who did not 
have a blood culture, leaving 9552 in the analysis.
Bacterial Isolates
Of 9552 neonates, 995 (10.4%) had CoNS isolated from 
blood culture, of which 150 of 995 (15.1%) died (Table 1). There 
were 689 of 9552 (7.2%) neonates with clinically significant iso-
lates, of whom 241 of 689 (35.0%) died (Table S1, Supplemental 
Digital Content 1, http://links.lww.com/INF/C774). There were 
587 of 9552 (6.1%) neonates with clinically nonsignificant patho-
gens or isolates of unknown significance from blood culture in this 
context (Streptococcus viridans, Coryneforms, Micrococcos spp. 
and Bacillus spp.), 124/587 (21.0%) died. Of all positive cultures, 
CoNS accounted for 995 of 2271 (43.8%) and (983/995, 98.8%) 
were sampled in the first 48 hours of admission. Overall mortality 
was 1873 of 9552 (19.6%).
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The probability of isolating CoNS decreased with increasing 
blood culture volume [odds ratio (OR) = 0.80 (0.71–0.90), P < 0.001 
for each mL increase], with no evidence of departure from linearity 
(LRT, P = 0.8), Figure 1A, while clinically significant organisms were 
more commonly isolated from higher blood culture volumes (Fig. 1B). 
Bacterial isolates are shown for each year in Figure S1, Supplemental 
Digital Content 1, http://links.lww.com/INF/C774, with reductions in 
isolations of CoNS after the introduction of a blood culture contami-
nation working group which reinforced training for hospital staff on 
using stringent aseptic techniques for blood culture collection.
1. Neonates With CoNS Isolated From Blood Cultures 
Compared With all Other Admissions (Primary Analysis)
Isolation of CoNS in neonates was not associated with inpa-
tient death [OR = 0.9 (0.7–1.0), P = 0.1]. It was, however, asso-
ciated with decreased duration of admission in survivors [OR for 
admission of 7 days or more = 0.9 (0.7–1.0), P = 0.040] when com-
pared with all other admissions.
In terms of clinical signs, CoNS isolation was associ-
ated with increased odds of convulsions [OR = 1.4 (1.0–1.8), 
P = 0.031], decreased odds of impaired conscious level and severe 
indrawing [OR = 0.8 (0.7–0.9), P = 0.025; OR = 0.9 (0.7–1.0), 
P = 0.065] compared with all other admissions (Table 2). There 
was no evidence of an association between CoNS and other clinical 
signs, admission weight or HIV exposure. With regards to timing 
of infection, neonates admitted after the first 48 hours of birth were 
more likely to have CoNS isolated [OR = 2.3 (1.8–2.8), P < 0.001] 
compared with admissions during days 0–2 of life, with evidence of 
departure from linearity across age categories, suggesting no fur-
ther increases with increasing age (LRT, P < 0.001), Table 2.
2. Neonates With CoNS Isolated From Blood Cultures 
Compared With Other Admissions Excluding Those 
With Clinically Significant Organisms Isolated
 Isolation of CoNS in neonates was not associated with inpa-
tient death after excluding neonates with presumed clinically sig-
nificant bacteremia [OR = 1.0 (0.8– 1.2),P = 0.9] nor was it associ-
ated with a difference in duration of admission (7 days or more) in 
survivors after excluding those with clinically significant bactere-
mia [OR = 0.9 (0.8–1.1),P = 0.3]. Clinical associations and timing 
of infections after exclusion of neonates with clinically significant 
bacteremia were similar to those described in the primary analysis 
TABLE 1. Demographic and Clinical Characteristics of Neonates Admitted to Kilifi 
County Hospital and Those With CoNS Isolated From Blood Sampling
Characteristic Total No CoNS (%) CoNS (%)
Age (d) <2 4283 4049 (47.3) 234 (23.5)
 2–6 2154 1876 (21.9) 278 (27.9)
 7–13 1863 1572 (18.4) 291 (29.2)
 14–20 747 631 (7.4) 116 (11.7)
 21–27 505 429 (5.0) 76 (7.6)
Sex Female 4033 3636 (42.5) 397 (39.9)
 Male 5519 4921 (57.5) 598 (60.1)
Weight of neonate at admission (g) <1500 1318 1216 (14.2) 102 (10.3)
 1500 to <2500 2819 2551 (29.8) 268 (26.9)
 2500 to <3500 4393 3894 (45.5) 499 (50.2)
 ≥3500 844 729 (8.5) 115 (11.6)
 Missing 178 167 (2.0) 11 (1.1)
HIV status Negative 4388 4047 (47.3) 341 (34.3)
 Positive 225 209 (2.4) 16 (1.6)
 No consent 20 15 (0.2) 5 (0.5)
 Period not tested 4265 3676 (43.0) 589 (59.2)
 Missing 654 44 (0.5) 610 (61.3)
Difficulty feeding No 8413 7530 (88.0) 883 (88.7)
 Yes 1111 1000 (11.7) 111 (11.2)
 Missing 28 27 (0.3) 1 (0.1)
 No 6406 5698 (66.6) 708 (71.2)
High Respiratory Yes 2814 2547 (29.8) 267 (26.8)
Rate (>60) Missing 332 312 (3.6) 20 (2.0)
Severe indrawing No 5966 5271 (61.6) 695 (69.8)
 Yes 3560 3263 (38.1) 297 (29.8)
 Missing 26 23 (0.3) 3 (0.3)
Movement only when stimulated (lethargy) No 7451 6691 (78.2) 760 (76.4)
 Yes 661 601 (7.0) 60 (6.0)
 Missing 1440 1265 (14.8) 175 (17.6)
Impaired conscious level No 7165 6367 (74.4) 798 (80.2)
 Yes 2361 2168 (25.3) 193(19.4)
 Missing 26 22 (0.3) 4 (0.4)
Convulsions No 9043 8125 (95.0) 918 (92.3)
 Yes 494 418 (4.9) 76 (7.6)
 Missing 15 14 (0.2) 1(0.1)
Temperature <35.5 3831 3547 (41.5) 284 (28.5)
 35.5–37.5 3038 2647 (30.9) 391 (39.3)
 >37.5 2580 2264 (26.5) 316 (31.8)
 Missing 103 99 (1.2) 4 (0.4)
Died No 7679 6834 (79.9) 845 (84.9)
 Yes 1873 1723 (20.1) 150 (15.1)
Duration of admission (d) <7 4439 3915 (57.3) 524 (62.0)
 7 or over 3240 2919 (42.7) 321 (38.0)
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(Table S2, Supplemental Digital Content 1, http://links.lww.com/
INF/C774).
3. Neonates With CoNS Isolated From Blood Cultures 
Compared With Neonates With Clinically Significant 
Isolates in Blood Cultures
Isolation of CoNS in neonates was associated with lower 
mortality compared to those with a clinically significant blood 
culture isolates [OR death during admission = 0.3 (0.3–0.4), P 
< 0.001] and decreased duration of admission in survivors [OR 
for admission of 7 days or more = 0.3 (0.3–0.4), P < 0.001]. 
The odds of clinical signs of pSBI were much reduced for all 
signs except convulsions, for which no difference in associa-
tion was found and it was not included in the final multivariable 
model (Table S3, Supplemental Digital Content 1, http://links.
lww.com/INF/C774).
A B
FIGURE 1. A: Probability of isolating CoNS from blood culture against the volume of blood in the culture. B: Probability of 
clinically significant isolate against blood culture volume. 
TABLE 2. Demographic and Clinical Characteristics Associated With Isolation 
of Cons From the Blood in Neonates Admitted to Kilifi County Hospital 1998–2013 
Compared With all Other Neonatal Admissions
Characteristic  
Univariable* Multivariable (9063)†
OR (95% CI) P OR (95% CI) P‡
Age (d)§ <2 1  1  
 2–6 2.5 (2.1–3.0)  2.3 (1.9–2.8)  
 7–13 3.1 (2.6–3.8)  3.0 (2.5–3.6)  
 14–20 3.1 (2.4–3.9)  2.9 (2.3–3.8)  
 21–27 3.0 (2.3–4.0) <0.001 2.9 (2.2–3.9) <0.001
Sex§ Female 1  1  
 Male 1.1 (1.0–1.3) 0.1 1.1 (1.0–1.3) 0.065
Difficulty feeding No 1    
 Yes 0.9 (0.7–1.1) 0.4   
RR > 60 bpm No 1    
 Yes 0.9 (0.8–1.1) 0.2   
Movement only when stimulated No 1    
 Yes 0.9 (0.7–1.2) 0.4   
Severe indrawing No 1  1  
 Yes 0.8 (0.7–1.0) 0.030 0.9 (0.7–1.0) 0.065
Impaired conscious level No 1  1  
 Yes 0.8 (0.7–1.0) 0.020 0.8 (0.7–1.0) 0.025
Convulsions No 1  1  
 Yes 1.3 (1.0–1.7) 0.042 1.3 (1.0–1.7) 0.042
Temperature <35.5 0.8 (0.7–1.0)    
 35.5–37.5 1    
 >37.5 1.0 (0.8–1.1) 0.3   
Blood volume§ Baseline 1  1  
 Per mL increase 0.8 (0.7–0.9) <0.001 0.8 (0.7–0.9) <0.001
*Adjusted for age, sex and blood volume.
†Adjusted for age, sex and blood volume and clinical signs associated in univariable analyses.
‡From the likelihood ratio test.
§A priori confounders.
CI indicates confidence interval; RR, respiratory rate.
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4. Neonates With Clinically Significant Isolates in Blood 
Cultures Compared With all Other Admissions
In neonates with clinically significant bacteremia, compared 
with all other neonatal admissions, the odds of death were high 
[OR = 3.1 (2.6–3.7), P < 0.001], and there was a prolonged dura-
tion of admission [OR for admission 7 days or more in survivors = 
1.7 (1.4–2.0), P < 0.001]. The odds of clinical signs of pSBI were 
increased for all clinical signs except convulsions, for which no 
difference in association was found and it was not included in the 
final multivariable model (Table S4, Supplemental Digital Content 
1, http://links.lww.com/INF/C774).
5. Neonates With Clinically Nonsignificant or Uncertain 
Significance Isolates (Excluding CoNS) Compared with 
all Other Admissions
In neonates with other presumed clinically nonsignificant 
pathogens or isolates of unknown significance from blood culture 
in this context (Streptococcus viridans, Coryneforms, Micrococ-
cos spp. and Bacillus spp.), there was no association with death 
compared with all other admissions [OR = 1.2 (1.0–1.5), P = 0.1) 
nor increased duration of admission [OR = 1.1 (0.9–1.3), P=0.5] 
nor association with clinical signs of pSBI (Table S5, Supplemental 
Digital Content 1, http://links.lww.com/INF/C774).
DISCUSSION
CoNS was frequently isolated from neonates admitted to 
KCH (~1 in 10). However, there was no evidence for an association 
with inpatient death or prolonged duration of admission compared 
with other admissions. This was despite empiric treatment with-
out a specific anti-Staphylococcal agent, although gentamicin may 
offer some cover for methicillin-sensitive isolates,32 suggesting that 
current treatment strategies do not need to be redirected to cover 
CoNS in this setting.
However, we cannot exclude that in a small number of indi-
vidual cases, CoNS may have been clinically significant, because 
the frequent isolation of CoNS, in 44% of positive blood cultures, 
may introduce sufficient misclassification that associations with 
adverse outcomes from true CoNS infections are undetectable. In 
addition, CoNS was associated with convulsions. It is possible that 
there is a true association between CoNS infection and convul-
sions, and investigation of CSF would be helpful to examine this. 
However, the association with convulsions may be a chance result 
or by confounding because it is possible that convulsions make it 
more difficult for a blood sample to be obtained and increase skin 
contamination. This was not accounted for by small blood volumes 
alone, which was adjusted for, but, for example, from movement 
during the procedure.
While the systematic collection of clinical and microbio-
logic data at admission is a strength of the study, as CoNS is more 
likely to act as a pathogen after admission (in association with 
indwelling devices) and here almost all sampling was done within 
48 hours of admission, it is possible that neonatal blood stream 
infection with CoNS occurring after admission could be systemati-
cally underrepresented.
However, the results of this study, suggest the majority of 
CoNS isolations were not clinically significant, implying that with 
44% of all positive neonatal blood cultures isolating CoNS, contam-
ination was frequent. This is higher than the 6%–32% of all positive 
blood cultures reported in Zambia and Ghana.13,15,24 This compari-
son should be made with caution, however, because these studies 
did not sample all neonatal admissions, and those most difficult to 
sample, and perhaps most likely to have CoNS isolated, would not, 
therefore, have been included. However, the introduction of quality 
improvement activity from 2009 did appear to reduce isolation of 
CoNS, and other organisms of uncertain clinical significance, sug-
gesting that contamination can be reduced.
The findings of the study are generalizable to the majority 
of health care facilities in sub-Saharan Africa with similar levels of 
care, where for example, indwelling devices are mostly limited to 
peripheral cannulas. There are, however, tertiary centers in Kenya,33 
and other middle-income countries in sub-Saharan Africa such as 
South Africa,34 where the use of indwelling devices and ventilation 
are common practice and where findings may differ. CoNS may yet 
emerge as an important pathogen in resource-poor settings as more 
invasive techniques to support neonatal care are used. To ensure 
clinical practice is based on the most up-to-date and relevant data, it 
is essential that long-term surveillance of serious bacterial neonatal 
infections is increased at all levels of health care in sub-Saharan 
Africa. In addition, if studies consistently report all blood stream 
isolates (whether regarded as clinically significant or not),35 we will 
increase our understanding of the etiology of neonatal sepsis in dif-
ferent settings, especially if contamination at the time of sampling 
can be reduced.
Our findings suggest that neonatal CoNS bacteremia is 
not associated with adverse clinical outcomes when neonates are 
treated according to standard WHO guidelines.
However, improving clinical surveillance in health care 
facility settings to inform case management is essential, to continue 
to direct treatment guidelines and inform changes, when needed, to 
local, national and international policies.
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